Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Akebia Therapeutics
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female Japanese participants ≥20 years of age
Diagnosis of chronic kidney disease (CKD) based on an estimated glomerular filtration rate ≤60 milliliters per minute per 1.73 meters squared (mL/min/1.73 m\^2)
Hemoglobin (Hb) ≤10.5 grams per deciliter (g/dL)
Not currently being treated with dialysis and not expected to start dialysis within 3 months of screening
You may not be if
Anemia due to a cause other than CKD or presence of active bleeding or recent blood loss
Sickle cell disease, myelodysplastic syndromes, bone marrow fibrosis, hematologic malignancy, myeloma, hemolytic anemia, thalassemia, or pure red cell aplasia
Red blood cell transfusion within 4 weeks prior to or during screening
Intravenous iron within 4 weeks prior to or during screening
Any use of erythropoiesis-stimulating agents within 6 weeks prior to or during screening
